PEAK PHARMACEUTICALS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
PEAK PHARMACEUTICALS, INC. (RMHI) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$12.34 thousand for the 12-month period ending 2013-09-30, per its 10-K filed 2013-12-27.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2013-12-27
- PEAK PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2013 was -$12.34K.
- PEAK PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2012 was -$20.22K.
- PEAK PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2011 was -$15.59K.
- PEAK PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2010 was -$23.59K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|
| 2013-09-30 | -$12.34K 10-K · filed 2013-12-27 | |
| 2012-09-30 | -$20.22K 10-K · filed 2013-12-27 | |
| 2011-09-30 | -$15.59K 10-K · filed 2013-12-27 | |
| 2010-09-30 | -$23.59K 10-K · filed 2013-12-27 | |
| 2009-09-30 | -$22.62K 10-K · filed 2013-12-27 | |
| 2008-09-30 | -$5.87K 10-K · filed 2013-12-27 |